Treatment(s) already received-None Posts on Medivizor

Evaluating the long-term effectiveness and safety of nivolumab plus ipilimumab versus nivolumab alone after surgery in patients with stage IV melanoma.

Posted by Medivizor on Jul 30, 2023 in Melanoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of nivolumab (Opdivo) plus ipilimumab (Yervoy) versus nivolumab alone given after surgery in patients with stage IV melanoma. The data showed that both nivolumab plus ipilimumab and nivolumab alone after surgery were effective compared with placebo and significantly improved survival without...

Evaluating the safety and effectiveness of FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of metastatic colorectal cancer

Posted by Medivizor on Jan 8, 2023 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus bevacizumab (Avastin) with or without atezolizumab (Tecentriq) on the outcomes of patients with metastatic (m) colorectal cancer (CRC). The study showed that adding atezolizumab to FOLFOXIRI plus...

Evaluating the effectiveness and safety of different platinum-based chemotherapy regimens given after surgery for the treatment of early-stage resected NSCLC.

Posted by Medivizor on Jan 3, 2023 in Lung cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of different platinum-based chemotherapy regimens given after surgery for the treatment of early-stage resected non-small cell lung cancer (NSCLC). The authors concluded that the combination of cisplatin (Platinol)-vinorelbine (Nevelbine) improved the outcomes of these patients. Also, the...

Evaluating the long-term effectiveness and safety of 3-month versus 6-month modified FOLFOX/CAPOX treatment after surgery in patients with stage 3 colon cancer.

Posted by Medivizor on Oct 13, 2022 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the long-term effectiveness and safety of 3-month versus 6-month modified FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin) or CAPOX (capecitabine and oxaliplatin) treatment after surgery in patients with stage 3 colon cancer. The data showed that 3-month modified FOLFOX/CAPOX treatment was as effective and safe as...

Comparing the effectiveness of surgery with and without oral uracil and tegafur plus leucovorin chemotherapy for patients with stage II colon cancer.

Posted by Medivizor on May 31, 2022 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of surgery with and without chemotherapy with uracil and tegafur (Uftoral; UFT) plus leucovorin (LV; folinic acid) in patients with stage II colon cancer. This study concluded that surgery with UFT/LV chemotherapy significantly improved survival outcomes in these patients. Some...

Comparing the overall survival rates to general life expectancy predictions after radical prostatectomy in patients with prostate cancer.

Posted by Medivizor on Aug 15, 2021 in Prostate cancer | 0 comments

In a nutshell This study compared the overall survival rates to general life expectancy predictions after radical prostatectomy (RP; prostate removal surgery) in German patients with localized prostate cancer. The study found that low- and intermediate-risk patients treated with RP have increased overall survival rates compared to general life...

Effects of adherence to homone therapy after surgery and radiation on the outcomes of older patients with early-stage breast cancer

Posted by Medivizor on Jun 13, 2021 in Breast cancer | 0 comments

In a nutshell This study aimed to investigate the effects of adherence to hormonal therapy (HT) and radiation on the outcomes of older patients with early-stage breast cancer (BC). This study concluded that the lack of adherence to HT and omitting radiation can lead to poorer outcomes for these...

Comparing 2 radiation treatments for elderly women with low-risk breast cancer

Posted by Medivizor on May 15, 2021 in Breast cancer | 0 comments

In a nutshell This article compared the outcomes of older patients with low-risk breast cancer treated with accelerated partial breast irradiation (APBI) or ultra-APBI. The authors found that both treatment methods resulted in similar outcomes and side effects in these patients. Some background Breast cancer is the most commonly diagnosed...

Evaluating the outcomes and safety of radiotherapy after immediate breast reconstruction following breast-conserving surgery

Posted by Medivizor on Apr 30, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the effectiveness and safety outcomes of radiotherapy (RT) after immediate autologous breast reconstruction (IABR) following breast-conserving surgery (BCS) in patients with breast cancer. The data showed that RT following IABR provided aesthetically satisfactory results with manageable side effects in these...

Does removal of the breast tumor improve survival in stage IV breast cancer with bone metastasis?

Posted by Medivizor on Mar 14, 2021 in Breast cancer | 0 comments

In a nutshell This study investigated the effects of the removal of the breast tumor in patients newly diagnosed with stage IV breast cancer and bone metastasis only. The data showed that removal of the breast tumor improved survival outcomes and decreased the recurrence rates in these patients. Some background In stage IV breast cancer (BC), the...

What is the optimal duration of chemotherapy after surgery for patients with stage III colon cancer?

Posted by Medivizor on Feb 7, 2021 in Colorectal cancer | 0 comments

In a nutshell This trial looked at the length of adjuvant chemotherapy (AC; chemotherapy after surgery) for patients with stage III colon cancer. The authors found that 3 months of AC resulted in similar survival with reduced levels of toxicity, and cost compared to 6 months. Some background AC has been standard care for patients with...

Intensity-modulated radiation therapy with simultaneously integrated boost leads to shorter treatment time with similar outcomes as conventional radiotherapy after surgery for breast cancer

Posted by Medivizor on Jan 2, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the effects of intensity-modulated radiation therapy (IMRT) with a simultaneously integrated boost (SIB) to conventional radiotherapy (CRT) with a sequential boost (SeqB) following breast-conserving surgery (BCS) in patients with breast cancer. The data showed that both radiotherapy techniques...

Treatment(s) already received-None Posts on Medivizor

Evaluating the long-term effectiveness and safety of nivolumab plus ipilimumab versus nivolumab alone after surgery in patients with stage IV melanoma.

Evaluating the safety and effectiveness of FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of metastatic colorectal cancer

Evaluating the effectiveness and safety of different platinum-based chemotherapy regimens given after surgery for the treatment of early-stage resected NSCLC.

Evaluating the long-term effectiveness and safety of 3-month versus 6-month modified FOLFOX/CAPOX treatment after surgery in patients with stage 3 colon cancer.

Comparing the effectiveness of surgery with and without oral uracil and tegafur plus leucovorin chemotherapy for patients with stage II colon cancer.

Comparing the overall survival rates to general life expectancy predictions after radical prostatectomy in patients with prostate cancer.

Effects of adherence to homone therapy after surgery and radiation on the outcomes of older patients with early-stage breast cancer

Comparing 2 radiation treatments for elderly women with low-risk breast cancer

Evaluating the outcomes and safety of radiotherapy after immediate breast reconstruction following breast-conserving surgery

Does removal of the breast tumor improve survival in stage IV breast cancer with bone metastasis?

What is the optimal duration of chemotherapy after surgery for patients with stage III colon cancer?

Intensity-modulated radiation therapy with simultaneously integrated boost leads to shorter treatment time with similar outcomes as conventional radiotherapy after surgery for breast cancer

Categories

Recent Posts

Archives

Treatment(s) already received-None Posts on Medivizor

Categories

Recent Posts

Archives

Thanks for your interest in Medivizor

Invalid email